AOBiome: AOBiome Reaches Key Enrollment Goal For Largest Clinical Trial Ever With A Topical Biotherapeutic

AOBiome Therapeutics, a leading clinical-stage biotechnology company focused on inflammation, announced the completion of enrollment in its Phase 2b clinical trial of pruritus (itching) associated with atopic dermatitis. This study builds on previous positive clinical trial results associated with the evaluation of its lead product candidate B244, a topical biotherapeutic, in patients with atopic [...]